2.76
0.00%
0.00
Arcadia Biosciences Inc Azioni (RKDA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
7.26%
1.255
|
1.17 | 1.597 | 1.389 | 1.509 |
Cost Of Revenue |
22.39%
0.82
|
0.67 | 1.102 | 0.981 | 0.825 |
Gross Profit |
13.00%
0.435
|
0.50 | 0.495 | 0.408 | 0.684 |
Operating Expenses
|
9.45%
3.499
|
3.864 | 3.737 | 4.199 | 4.732 |
Benefits Costs and Expenses |
2.85%
3.678
|
3.786 | 4.081 | 5.18 | 10.89 |
Costs And Expenses |
4.74%
4.319
|
4.534 | 4.839 | 5.18 | 5.557 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Operating Income/Loss |
8.92%
-3.064
|
-3.364 | -3.242 | -3.791 | -4.048 |
Net Interest Income/Expense |
71.34%
0.045
|
0.157 | 0.133 | 0.207 | 0.198 |
Interest Income/Expense After Provision For Losses |
71.34%
0.045
|
0.157 | 0.133 | 0.207 | 0.198 |
Income/Loss From Continuing Operations Before Tax |
7.38%
-2.423
|
-2.616 | -2.484 | 0.818 | -9.384 |
Income/Loss From Continuing Operations After Tax |
7.62%
-2.423
|
-2.623 | -2.484 | 0.818 | -9.384 |
Income/Loss From Discontinued Operations, Net Of Tax |
100.00%
-
|
-0.23 | -0.083 | - | - |
Net Income/Loss
|
15.07%
-2.423
|
-2.853 | -2.567 | 0.818 | -9.384 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | -0.005 | - |
Basic Average Shares |
3,175%
1.3617
|
0.0416 | 1.3595 | 1.3584 | 0.8644 |
Diluted Average Shares |
3,175%
1.3617
|
0.0416 | 1.3595 | 1.3584 | 0.8644 |
Basic Earnings Per Share |
-1.78
|
- | -1.89 | 0.61 | -10.86 |
Diluted Earnings Per Share |
-1.78
|
- | -1.89 | 0.61 | -10.86 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):